Genex Pharmaceutical GENX Stock
Genex Pharmaceutical Price Chart
Genex Pharmaceutical GENX Financial and Trading Overview
| Genex Pharmaceutical stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0001 USD |
| Volume | 3.6K USD |
| Avg. Volume | 2.56K USD |
| Market Cap | 110.64K USD |
| Beta (5Y Monthly) | -36.02676 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GENX Valuation Measures
| Enterprise Value | 146.64K USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.034179088 |
| Price/Book (mrq) | 0.00037593982 |
| Enterprise Value/Revenue | 0.045 |
| Enterprise Value/EBITDA | 0.281 |
Trading Information
Genex Pharmaceutical Stock Price History
| Beta (5Y Monthly) | -36.02676 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
GENX Share Statistics
| Avg. Volume (3 month) | 2.56K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2007 |
| Most Recent Quarter (mrq) | December 31, 2007 |
| Next Fiscal Year End | December 31, 2008 |
Profitability
| Profit Margin | 10.58% |
| Operating Margin (ttm) | 14.39% |
| Gross Margin | 88.79% |
| EBITDA Margin | 16.13% |
Management Effectiveness
| Return on Assets (ttm) | 4.04% |
| Return on Equity (ttm) | 7.78% |
Income Statement
| Revenue (ttm) | 3.24M USD |
| Revenue Per Share (ttm) | 0.18 USD |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | 2.87M USD |
| EBITDA | 522.28K USD |
| Net Income Avi to Common (ttm) | 342.55K USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 430.12K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 574.98K USD |
| Total Debt/Equity (mrq) | 12.13 USD |
| Current Ratio (mrq) | 0.615 |
| Book Value Per Share (mrq) | 0.266 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 529.66K USD |
| Levered Free Cash Flow (ttm) | 1.25M USD |
Profile of Genex Pharmaceutical
| Country | United States |
| State | N/A |
| City | Tianjin City |
| Address | 1801 Guangyin Building |
| ZIP | 300074 |
| Phone | 86 22 2337 0440 |
| Website | N/A |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 86 |
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin City, the People's Republic of China.
Q&A For Genex Pharmaceutical Stock
What is a current GENX stock price?
Genex Pharmaceutical GENX stock price today per share is 0.0001 USD.
How to purchase Genex Pharmaceutical stock?
You can buy GENX shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genex Pharmaceutical?
The stock symbol or ticker of Genex Pharmaceutical is GENX.
Which industry does the Genex Pharmaceutical company belong to?
The Genex Pharmaceutical industry is Drug Manufacturers-Specialty & Generic.
How many shares does Genex Pharmaceutical have in circulation?
The max supply of Genex Pharmaceutical shares is 1.11B.
What is Genex Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Genex Pharmaceutical PE Ratio is now.
What was Genex Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Genex Pharmaceutical EPS is 0 USD over the trailing 12 months.
Which sector does the Genex Pharmaceutical company belong to?
The Genex Pharmaceutical sector is Healthcare.